Skip to content

Study compares Propranolol and Metoprolol for migraine prophylaxis in a hospital trial.

Comparative Evaluation of Efficacy and Safety of Oral Propranolol Vs Oral Metoprolol for Prophylaxis in Patients of Migraine in a Tertiary Care Hospital: A Prospective Randomized Double Blind Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073430
Enrollment
80
Registered
2024-09-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: Propranolol: Oral Propranolol 40mg once daily after breakfast for duration of 4 months Control Intervention1: Metoprolol: Oral Metoprolol 50mg once daily after breakfast for duration of

Sponsors

Dr Ramizahmad Maiyuddinbhai Mansuri
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient will be taken as per International Headache Society Criteria for Migraine with Aura. Patient will be taken as per International Headache Society Criteria for Migraine without Aura. Patients who will be willing to take part in the study with signed and written informed consent. Patients aged between 18-65 years. Patients could be of both male and female.

Exclusion criteria

Exclusion criteria: Pregnant , breast feeding, child bearing age using contraception. Patients having asthma, bradycardia and COPD. History of Bronchospasm. Patients having Coronary Artery Diseases . Patients less than 18years & more than 65years. Patient having chronic in capacitating illness eg.AIDS,cancer,TB. Patient whose primary headaches were other than migraine headaches e.g. With a clinical history of stroke or Transient Ischemic Attack.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Propranolol versus Metoprolol as Prophylactic Agent in Migraine using The Migraine Disability Assessment Test and Headache Impact Test 6Timepoint: Baseline 4 weeks 8 weeks and 12 weeks

Secondary

MeasureTime frame
To compare the Adverse drug reactions between Propranolol versus Metoprolol which will be used as prophylactic agent in Migraine by maintaining Headache DiaryTimepoint: Baseline 4 weeks 8 weeks & 12 weeks

Countries

India

Contacts

Public ContactDr Devendra Singh Kushwah

Gajra Raja Medical College

dev_singh433@yahoo.com8889925777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026